Select Medical (NYSE:SEM) Upgraded at StockNews.com

StockNews.com upgraded shares of Select Medical (NYSE:SEM) from a hold rating to a buy rating in a research note released on Monday morning.

Several other equities research analysts also recently commented on the stock. UBS Group dropped their price objective on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Royal Bank of Canada boosted their target price on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Finally, Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $39.50.

Select Medical Stock Down 3.6 %

Shares of NYSE SEM opened at $19.64 on Monday. Select Medical has a 12-month low of $18.02 and a 12-month high of $40.98. The firm has a market cap of $2.54 billion, a PE ratio of 9.18, a P/E/G ratio of 0.65 and a beta of 1.45. The company’s fifty day simple moving average is $20.61 and its 200 day simple moving average is $30.16. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the prior year, the business posted $0.46 earnings per share. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Select Medical will post 1.97 earnings per share for the current fiscal year.

Insider Activity at Select Medical

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the transaction, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. The trade was a 59.26 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now owns 30,356 shares in the company, valued at approximately $605,602.20. This represents a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 19.14% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Allspring Global Investments Holdings LLC raised its stake in shares of Select Medical by 172.3% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 16,579 shares of the health services provider’s stock worth $312,000 after acquiring an additional 10,491 shares in the last quarter. Empowered Funds LLC acquired a new stake in Select Medical during the 4th quarter valued at approximately $5,903,000. Kingsview Wealth Management LLC boosted its holdings in Select Medical by 92.9% in the fourth quarter. Kingsview Wealth Management LLC now owns 106,623 shares of the health services provider’s stock valued at $2,010,000 after purchasing an additional 51,361 shares during the last quarter. Jennison Associates LLC grew its holdings in Select Medical by 542.7% during the fourth quarter. Jennison Associates LLC now owns 115,185 shares of the health services provider’s stock worth $2,171,000 after acquiring an additional 97,264 shares during the period. Finally, Financial Strategies Group Inc. grew its stake in shares of Select Medical by 37.6% during the 4th quarter. Financial Strategies Group Inc. now owns 14,738 shares of the health services provider’s stock worth $269,000 after purchasing an additional 4,029 shares during the period. Hedge funds and other institutional investors own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.